Why Aclaris Therapeutics Topped the Market on Tuesday
Investors were cheered by the latest laboratory news from the company.
Stay updated with breaking news from Gail Cawkwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investors were cheered by the latest laboratory news from the company.
ICPT earnings call for the period ending September 30, 2021.
Intercept Appoints M. Michelle Berrey, M.D., M.P.H., as President of Research & Development and Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
Operator Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I'll be your operator for today's call. [Operator Instructions] I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin. Lisa DeFrancesco -- Senior Vice President of Investor Relations and Corporate Affairs Thank you. Good morning, and thank you for joining us on today's call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I'd like ...
Operator Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2020 Intercept Pharmaceuticals Earnings Call. [Operator Instructions] I'd now like to hand the conference over to your host today, Ms. Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs. Please go ahead. Lisa DeFrancesco -- Senior Vice President, Corporate Affairs & Investor Relations Thank you. Good morning, and thank you for joining us on today's call. This morning we issued a press release announcing our fourth quarter and full year 2020 results and financial position...